Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors

American Heart Journal

Volumn 131, Issue 1, 1996, Pages 153-157

  Panina, Gaia ^b   Khot, Umesh N ^b   Nunziata, Enrico ^b   Cody, Robert J ^b   Binkley, Philip F ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLOSEQUINAN;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HEART RATE; HOLTER MONITORING; HUMAN; MULTICENTER STUDY; POWER SPECTRUM; PRIORITY JOURNAL;

EID: 0030069614     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90064-2     Document Type: Article

References (26)

1. Levine TB, Francis GS, Goldsmith SR, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1981;49:1659-66.
2. Cohn JN, Levine TB, Olivari MT, Gartberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-23.
3. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988;61:1292-9.
4. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-72.
5. Binkley PF, Cody RJ. Measurement of the autonomic profile in congestive heart failure by spectral analysis of heart rate variability. Heart Failure 1992;8:154-76.
6. Lehmann M, Wybitul K, Spielberg B, Keul J. Correlations of hemodynamic parameters with plasma catecholamines in patients with congestive cardiomyopathy. Clin Cardiol 1982;5:493-9.
7. Viquerat CE, Daly P, Swedberg K, Evers C, Curran D, Parmley WW, Chatterjee K. Endogenous catecholamine levels in chronic heart failure: relation to the severity of hemodynamic abnormalities. Am J Med 1985;78:455-60.
8. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, SundolfG, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73:615-21.
9. Ferguson DW, Berg WJ, Sanders JS, Kempf JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990;16:1125-34.
10. Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA. Double blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. J Am Coll Cardiol 1993;22:65-72.
11. Berger KD, Akselrod S, Gordon D, Cohen RJ. An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng 1986;33:900-4.
12. Marple SL Jr. Digital spectral analysis with applications. Englewood Cliffs, NJ: Prentice Hall, 1987:130-65.
13. Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ. Sustained augmentation of parasympathetic tone with angiotensin converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655-61.
14. Packer M, Lee WH, Medina N, Yushak M, Bernstein JL, Kessler PD. Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol 1987;10:1303-11.
15. Smith RF, Johnson G, Ziesche S, Bhat G, Blankenship K, Cohn JN. Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(suppl 6):V188-93.
16. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989;64:1162-7.
17. Benedict CR, Johnstone DE, Bourassa MG, Bittner V, Blackburn G, Greenberg B, Kay R, Kirlin P, Kohn RM, McInyre K, Weiss MB, Weiner D, Yusuf S for SOLVD Investigators. Relationship between neurohormonal activation, severity of left ventricular dysfunction and clinical status. J Am Coll Cardiol 1991;17:21A.
18. Oren R, Roach PJ, Berg WJ, Schobel HP, Ferguson DW. Resting muscle sympathetic activity correlates with right rather than left ventricular ejection fraction in human heart failure. J Am Coll Cardiol 1991; 17:21A.
19. Adamopoulos S, Piepoli M, McCance A, Bernardi L, Radaelli A, Ormerod O, Forfar C, Sleight P, Coats AJS. Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1992; 70:1576-82.
20. Rea RF, Eckberg DL, Fritch JM, Goldstein DS. Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans. Am J Physiol 1990;258:R982-6.
21. Kienzle MG, Ferguson DW, Birkett CL, Myers GA, Berg WJ, Mariano DJ. Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992;69:761-7.
22. Cogliati C, Guzzetti S, Turiel E, Crema C. Prognostic value of indexes of neural cardiovascular control in chronic heart failure. J Heart Failure 1993;1:1042-7.
23. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol 1993;72:211-22.
24. Bristow MR, Ginsburg R, Minobe W, Cubiciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison D, Stingson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
25. Spann JF, Sonnenblick EH, Cooper T, Chidsey CA, William VL, Braunwald E. Cardiac norepinephrine stores and the contractile state of heart muscle. Circ Res 1966;19:317-25.
26. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, Ceconi C, Cerutti S, Tavazzi L. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994;71:422-30.